TOKAI (9729) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Feb, 2026Executive summary
Net sales for the nine months ended December 31, 2025, rose 7.2% year-over-year to ¥119,866 million, with operating profit up 20.4% to ¥6,830 million and ordinary profit up 18.2% to ¥7,318 million, both reaching record highs for the third quarter of FY3/26.
Profit attributable to owners of parent increased 16.7% year-over-year to ¥5,143 million, and comprehensive income surged 63.6% to ¥6,066 million.
Growth was driven by strong performance in the rental business, expansion in the Dispensing Pharmacy Business, and contributions from newly consolidated companies.
Financial highlights
Gross profit for the nine-month period increased to ¥28,839 million from ¥25,931 million year-over-year.
Basic earnings per share for the period were ¥154.51, up from ¥129.28 in the prior year.
Net sales rose 7.2% year-over-year to ¥119,866 million in 3Q FY3/26.
Total assets as of December 31, 2025, were ¥117,716 million, up from ¥114,289 million at the previous fiscal year-end.
Net assets decreased to ¥83,488 million from ¥85,841 million as of March 31, 2025.
Outlook and guidance
Full-year net sales forecast for the fiscal year ending March 31, 2026, is ¥157,976 million, a 5.6% increase year-over-year.
Operating profit is projected at ¥8,216 million (up 0.3%), ordinary profit at ¥8,590 million (down 2.7%), and profit attributable to owners of parent at ¥5,499 million (up 16.3%).
Basic earnings per share for the full year are forecast at ¥178.24.
M&A is positioned as a key growth strategy, especially in elderly care equipment rental, aiming for a 10% market share nationwide.
Latest events from TOKAI
- Record sales and profit growth, higher dividends, and capital returns planned.9729
Q2 202611 Nov 2025 - Record sales and operating profit, but net profit fell; outlook and dividend raised.9729
Q1 20267 Aug 2025 - Net sales and net income increased, but full-year profit is forecast to decline.9729
Q2 202513 Jun 2025 - Sales and profits rose, with strong Q1 gains and stable full-year outlook.9729
Q1 202513 Jun 2025 - Record sales and profit growth, but net income fell on impairments; outlook remains positive.9729
Q4 20256 Jun 2025 - Record sales growth, but profit pressured by higher costs and securities losses.9729
Q3 20255 Jun 2025